Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAJESH KUMAR BAGAI

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1306866736
CMS profile
58775
Location
GLENDALE, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$9,330.93

271 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $5,812.83 267
Consulting Fee $3,495.00 3
Education $23.10 1

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $2,019.62 14
Incyte Corporation $1,045.19 9
Geron Corporation $984.56 2
Novartis Pharmaceuticals Corporation $407.77 20
ABBVIE INC. $354.93 27
PFIZER INC. $335.60 17
E.R. Squibb & Sons, L.L.C. $321.00 21
Merck Sharp & Dohme LLC $306.01 11
Celgene Corporation $282.19 16
Daiichi Sankyo Inc. $276.21 13
Caris MPI, Inc. $219.82 1
Janssen Biotech, Inc. $208.85 11
Bayer Healthcare Pharmaceuticals Inc. $148.95 9
GENZYME CORPORATION $145.06 5
GlaxoSmithKline, LLC. $140.03 11
Novo Nordisk Inc $125.00 1
Lilly USA, LLC $118.39 4
Genentech USA, Inc. $110.75 5
ARRAY BIOPHARMA INC $100.47 5
BeOne Medicines USA, Inc. $92.05 4
Genmab U.S., Inc. $84.24 3
EMD Serono, Inc. $76.37 3
Adaptive Biotechnologies Corporation $73.66 4
Deciphera Pharmaceuticals Inc. $73.33 3
ADC THERAPEUTICS AMERICA, INC. $71.98 3
TerSera Therapeutics LLC $69.57 2
SERVIER PHARMACEUTICALS LLC $67.92 3
JAZZ PHARMACEUTICALS INC. $67.29 2
Eisai Inc. $66.88 3
PUMA BIOTECHNOLOGY, INC. $63.79 3
PharmaEssentia USA Corporation $62.75 3
Aveo Pharmaceuticals, Inc. $61.20 3
Syndax Pharmaceuticals, Inc. $59.27 2
Astellas Pharma US Inc $55.65 2
SOBI, INC $55.38 2
Gilead Sciences, Inc. $55.20 3
Boehringer Ingelheim Pharmaceuticals, Inc. $52.98 2
SpringWorks Therapeutics, Inc. $48.93 2
Ipsen Biopharmaceuticals, Inc $45.48 2
KYOWA KIRIN, INC. $38.84 2
Regeneron Healthcare Solutions, Inc. $38.24 1
Blueprint Medicines Corporation $38.02 1
TAIHO ONCOLOGY, INC. $34.15 1
Sumitomo Pharma America, Inc. $30.68 1
PROGENICS PHARMACEUTICALS, INC. $28.54 1
Rigel Pharmaceuticals, Inc. $27.37 1
Kite Pharma, Inc. $26.95 1
Stemline Therapeutics Inc. $26.38 1
Alexion Pharmaceuticals, Inc. $20.20 1
Amneal Pharmaceuticals LLC $18.95 1
Takeda Pharmaceuticals U.S.A., Inc. $17.27 1
Azurity Pharmaceuticals, Inc. $15.97 1
Exelixis Inc. $15.05 1

Page 4 of 6; records 151–200 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAJESH KUMAR BAGAI

NPI 1306866736 · CMS profile ID 58775

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

GLENDALE, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 6; records 151–200 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1306866736?year=2025&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAJESH KUMAR BAGAI, NPI 1306866736, CMS profile ID 58775. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 6; records 151–200 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1306866736?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). RAJESH KUMAR BAGAI, NPI 1306866736, CMS profile ID 58775. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 6; records 151–200 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1306866736?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
RAJESH KUMAR BAGAI, NPI 1306866736, CMS profile ID 58775, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 6; records 151–200 of 271 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1306866736?year=2025&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

271 matching records · $9,330.93 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 271 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 271.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $22.6406/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228865597 CMS
ABBVIE INC. $18.6506/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201456017 CMS
AstraZeneca Pharmaceuticals LP $32.7806/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206246034 CMS
Eisai Inc. $21.7706/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244506361 CMS
Novartis Pharmaceuticals Corporation $20.5906/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200069722 CMS
GENZYME CORPORATION $33.7306/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233381083 CMS
PFIZER INC. $7.6705/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231717923 CMS
AstraZeneca Pharmaceuticals LP $23.1005/28/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1206679261 CMS
AstraZeneca Pharmaceuticals LP $21.6305/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206775935 CMS
ABBVIE INC. $7.6405/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201456015 CMS
GENZYME CORPORATION $33.5105/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233381089 CMS
ABBVIE INC. $14.7105/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201456013 CMS
Merck Sharp & Dohme LLC $24.6705/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238226612 CMS
E.R. Squibb & Sons, L.L.C. $19.0405/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184512208 CMS
Novartis Pharmaceuticals Corporation $18.4305/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200069724 CMS
BeOne Medicines USA, Inc. $18.5505/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202907154 CMS
ABBVIE INC. $4.9005/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201456011 CMS
PharmaEssentia USA Corporation $24.6905/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246829475 CMS
ARRAY BIOPHARMA INC $21.0305/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228876726 CMS
Celgene Corporation $1.4305/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184512196 CMS
Celgene Corporation $8.7005/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184512198 CMS
JAZZ PHARMACEUTICALS INC. $33.0205/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234319346 CMS
Exelixis Inc. $15.0505/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218801727 CMS
Merck Sharp & Dohme LLC $34.7205/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238174239 CMS
Alexion Pharmaceuticals, Inc. $20.2005/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202920514 CMS
Daiichi Sankyo Inc. $9.6105/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197098731 CMS
Janssen Biotech, Inc. $19.9805/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174468964 CMS
Janssen Biotech, Inc. $25.9605/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174471716 CMS
Daiichi Sankyo Inc. $13.4805/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197065903 CMS
Novartis Pharmaceuticals Corporation $22.2705/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200069726 CMS
Daiichi Sankyo Inc. $29.9405/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197066893 CMS
EMD Serono, Inc. $31.2905/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236896816 CMS
Celgene Corporation $33.2904/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184512192 CMS
Incyte Corporation $25.2304/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226084155 CMS
Celgene Corporation $23.2604/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184512182 CMS
PFIZER INC. $23.6204/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230063273 CMS
AstraZeneca Pharmaceuticals LP $25.4804/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206328392 CMS
Janssen Biotech, Inc. $20.8804/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174470879 CMS
Janssen Biotech, Inc. $20.3804/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174471474 CMS
Lilly USA, LLC $25.5104/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186895029 CMS
Novartis Pharmaceuticals Corporation $20.8604/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200043910 CMS
ABBVIE INC. $16.9404/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201456009 CMS
Gilead Sciences, Inc. $17.3504/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234554787 CMS
E.R. Squibb & Sons, L.L.C. $2.4604/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184512178 CMS
TAIHO ONCOLOGY, INC. $34.1504/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211408459 CMS
Adaptive Biotechnologies Corporation $16.1004/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1254934199 CMS
TerSera Therapeutics LLC $34.5204/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244061128 CMS
Bayer Healthcare Pharmaceuticals Inc. $15.3104/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225454767 CMS
PROGENICS PHARMACEUTICALS, INC. $28.5404/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245237157 CMS
E.R. Squibb & Sons, L.L.C. $15.2704/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184512186 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,446.60 163
PY2020 $1,557.86 87
PY2021 $2,909.92 178
PY2022 $4,444.50 208
PY2023 $4,417.14 201
PY2024 $4,736.75 213
PY2025 $9,330.93 271

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $24,613.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $6,669.00 12/05/2025 Non-covered Recipient Entity
IRONWOOD PHYSICIANS PC
A Randomized, Open-label Phase 3 Study of Amivantamab + FOLFIRI Versus Cetuximab/Bevacizumab + FOLFIRI in Participants With KRAS/NRAS and BRAF Wildtype Recurrent Metastatic Colorectal Cancer Who Have Received Prior Chemotherapy No dispute reported 06/30/2026 1175400941
Principal investigator 1 Janssen Research & Development, LLC $4,244.00 09/29/2025 Non-covered Recipient Entity
IRONWOOD PHYSICIANS PC
A Randomized, Open-label Phase 3 Study of Amivantamab + FOLFIRI Versus Cetuximab/Bevacizumab + FOLFIRI in Participants With KRAS/NRAS and BRAF Wildtype Recurrent Metastatic Colorectal Cancer Who Have Received Prior Chemotherapy No dispute reported 06/30/2026 1175400948
Principal investigator 1 Janssen Research & Development, LLC $13,700.00 09/05/2025 Non-covered Recipient Entity
IRONWOOD PHYSICIANS PC
A Randomized, Open-label Phase 3 Study of Amivantamab + FOLFIRI Versus Cetuximab/Bevacizumab + FOLFIRI in Participants With KRAS/NRAS and BRAF Wildtype Recurrent Metastatic Colorectal Cancer Who Have Received Prior Chemotherapy No dispute reported 06/30/2026 1175400936